OncoTherapy Science Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Employees
  • 67

Employees

  • Stock Symbol
  • 4564

Stock Symbol

  • Share Price
  • $0.15
  • (As of Wednesday Closing)

OncoTherapy Science General Information

Description

OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Corporate Office
  • 3-2-1 Sakado
  • Kawasaki-shi
  • Kanagawa, Takatsu-ku 213-0012
  • Japan
+81 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoTherapy Science Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.15 $0.14 $0.10 - $0.32 $33.2M 218M 7.49M -$0.04

OncoTherapy Science Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021
EV 29,483 60,495 89,605 163,698
Revenue 6,414 8,383 10,269 3,135
EBITDA (8,248) (22,736) (14,259)
Net Income (8,489) (8,263) (22,890) (14,727)
Total Assets 6,603 11,343 22,001 30,532
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OncoTherapy Science Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OncoTherapy Science‘s full profile, request access.

Request a free trial

OncoTherapy Science Patents

OncoTherapy Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230357328-A1 Sars-cov-2 protein-derived peptide and vaccine containing same Pending 25-Aug-2021 0000000000
US-20240067679-A1 Sars-cov-2 protein-derived peptide and vaccine containing same Pending 25-Aug-2021 0000000000
AU-2021418202-A1 Sars-cov-2 protein-derived peptide and vaccine containing same Pending 05-Jan-2021
AU-2021351255-A1 Sars-cov-2 protein-derived peptide and vaccine containing same Pending 30-Sep-2020 0000000000000
JP-2022191531-A T-cell receptor expressed by human t-cells that recognize peptide derived from urlc10 or peptide derived from depdc1 Pending 24-Sep-2019
To view OncoTherapy Science’s complete patent history, request access »

OncoTherapy Science Executive Team (2)

Name Title Board Seat Contact Info
Jae-Hyun Park Director
You’re viewing 1 of 2 executive team members. Get the full list »

OncoTherapy Science Board Members (5)

Name Representing Role Since
Tomoaki Fujioka OncoTherapy Science Board Member 000 0000
Yuichi Komine OncoTherapy Science Board Member 000 0000
You’re viewing 2 of 5 board members. Get the full list »

OncoTherapy Science Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoTherapy Science ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view OncoTherapy Science’s complete esg history, request access »

OncoTherapy Science FAQs

  • When was OncoTherapy Science founded?

    OncoTherapy Science was founded in 2001.

  • Where is OncoTherapy Science headquartered?

    OncoTherapy Science is headquartered in Kanagawa, Japan.

  • What is the size of OncoTherapy Science?

    OncoTherapy Science has 67 total employees.

  • What industry is OncoTherapy Science in?

    OncoTherapy Science’s primary industry is Drug Discovery.

  • Is OncoTherapy Science a private or public company?

    OncoTherapy Science is a Public company.

  • What is OncoTherapy Science’s stock symbol?

    The ticker symbol for OncoTherapy Science is 4564.

  • What is the current stock price of OncoTherapy Science?

    As of 12-Jun-2024 the stock price of OncoTherapy Science is $0.15.

  • What is the current market cap of OncoTherapy Science?

    The current market capitalization of OncoTherapy Science is $33.2M.

  • What is OncoTherapy Science’s current revenue?

    The trailing twelve month revenue for OncoTherapy Science is $6.41M.

  • What is OncoTherapy Science’s annual earnings per share (EPS)?

    OncoTherapy Science’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »